In this week’s issue:
- CIHR Fellowship Award Faculty of Medicine internal signature deadline is October 23rd, 2015. Full details are available at https://mednet.med.ubc.ca/Research/GrantApplications/CIHR/Pages/CIHR-Fellowship.aspx (final reminder).
- NSERC Discovery Grant Faculty of Medicine internal signature deadline is also October 23rd, 2015. Full details are available at https://mednet.med.ubc.ca/Research/GrantApplications/NSERCDiscoverGrant/Pages/default.aspx (final reminder).
- Alliance for Cancer Gene Therapy – 2015 Wendy Walk/ACGT Sarcoma Clinical Research Grant (final reminder)
- Canadian Breast Cancer Foundation – Call for Proposals (final reminder)
- Citizens United for Research in Epilepsy – 2016 Grant Cycle
- Alzheimer’s Drug Discovery Foundation – Program to Accelerate Clinical Trails
- Cancer Research UK – Grand Challenge Awards
- American Society for Reproductive Medicine – 2015 Research Grants
Awards and Honours:
- Ho-Am Foundation – Ho-Am Prize
- Weill Cornell Medical College – Drukier Prize in Children’s Health Research
- Warren Alpert Foundation – Warren Alpert Foundation Prize
- Michael Smith Foundation for Health Research – Scholar Info Sessions
- UBC School of Population and Public Health Grand Rounds – Beyond healthcare ethics vs. public health ethics: Why we need new bioethics thinking to address today’s wicked health problems
- UBC Pathology and Laboratory Medicine Professional Advancement Learning Series – Making things better: Using LEAN methodology for continuous improvement
- UBC Faculty of Medicine Continuing Professional Development – Ophthalmology Update: Knowledge and Skills Seminar for Emergency Physicians (final reminder)
LOI Deadline: October 26, 2015; 8am PST
Application Deadline (by invitation): January 18, 2016; 8am PST
Alliance for Cancer Gene Therapy, Inc. (ACGT) funds research aimed at furthering the development of cell and gene therapy approaches to the treatment of cancer. To this end, ACGT offers awards in Clinical Translation of Cell and Gene Therapy for Cancer, to qualified scientists at the assistant professor level and above. This award is specifically for those conducting Cell and Gene Therapy Research for sarcoma.
The award provides up to a maximum of $500,000 distributed over 2-3 years, inclusive of a maximum of 10% indirect costs. The funds may be used at the recipient’s discretion for salary, technical assistance, supplies, animals or capital equipment, but may not support staff not directly related to the project, e.g. secretaries or administrative assistants. Purchase of equipment is not allowed in the final year of the grant. Continued support is contingent upon submission and approval of a non-competitive renewal application each year.
For further details, please visit the ACGT website.
Deadline: October 30, 2015
As the leading volunteer-based organization dedicated to creating a future without breast cancer, the Canadian Breast Cancer Foundation (CBCF) works collaboratively to fund, support and advocate for relevant and innovative breast cancer research; meaningful education and awareness programs; early diagnosis and effective treatment; and a positive quality of life for those living with breast cancer.
The CBCF has recently launched the following funding opportunities:
- Breast Cancer Research Grant
- Doctoral and Postgraduate Fellowship Grant
- Community Health Grant
Please visit the CBCF website for further details.
LOI Deadline: November 19, 2015, 9pm ET (Cycle 1); March 16, 2016, 9pm ET (Cycle 2)
Full Application Deadline: February 16, 2016, 9pm ET (Cycle 1); June 15, 2016, 9pm ET (Cycle 2)
CURE awards grants for novel research projects that address finding the cures for epilepsy and address the goal of “no seizures, no side-effects.”
Specifically we fund research that works to understand and prevent epilepsy, identify disease modifying or eliminating therapies, eliminate SUDEP, and reverse deficits caused by frequent seizures.
CURE is now accepting LOIs for their first 2016 grant cycle. Currently accepting applications for:
- Innovator Award – $50,000 USD paid over 1 year
- Taking Flight Award – $100,000 USD paid over 1 year
- CURE Epilepsy Award – $250,000 USD paid over 2 years
Please visit the CURE website for further information regarding these opportunities.
LOI Deadline: November 26, 2015
Full Application Deadline: December 10, 2016
The true test for new Alzheimer’s drugs is in human clinical trials. Numerous treatments for Alzheimer’s disease have been shown to be safe and to have some positive effect when tested in animal models of Alzheimer’s disease. However, many of these potentially successful treatments have not been brought to human trials because of the increased cost and risk at this stage of research.
The ADDF is responding to this problem through the Program to Accelerate Clinical Trials (PACT). The goal of this Request for Proposals (RFP) is to increase the number of innovative treatments tested in humans for Alzheimer’s disease, related dementias and cognitive aging. This program will fund biomarker-based pilot clinical trials for Alzheimer’s disease and in some cases will also support Phase I safety testing and IND-enabling studies to accelerate new drugs into trials. Through this PACT RFP, the ADDF is also interested in supporting clinical biomarker development programs and biomarker-based trials to validate putative mechanisms of action for targeted pharmacological and non-pharmacological approaches to prevention.
The ADDF now has funding available to consider trials budgeted at up to $3million+ per application. This increased funding will be available for a limited time only.
Please visit the ADDF website for further details.
Expression of Interest Deadline: February 12, 2016
Grand Challenge awards are the most ambitious cancer research grants in the world. They’re intended to catalyse a revolution in how we prevent, diagnose, and treat cancer by bringing together the brightest minds around the globe, providing the freedom to undertake innovative, game-changing research.
We’re looking for applications from interdisciplinary teams with novel, exciting ways of solving one of seven Grand Challenges, which together encompass some of the most important unanswered questions in cancer research. If you can convince us you’re on to something extraordinary, we’ll give your team up to £20m to prove it. Cancer Research UK is seeking scientific adventurers who are willing to take risks in exchange for the ultimate reward – making cancer a disease that no longer inspires fear. If you can rise to the challenge, come and change the future with us.
We will support the best scientists from around the world and enable the optimal mix of disciplines and approaches. We anticipate successful Grand Challenge teams will:
- comprise a principal and up to 7 co-investigators from recognised academic institutions or for-profit companies
- be interdisciplinary
- include a patient advocate
Teams must have a strong UK component with at least 25% of the grant spent in the UK. Commercial collaboration is encouraged. Expressions of interest must be received by 12 February 2016.
For further information, please visit the Cancer Research UK website.
Deadline: March 2, 2016
The American Society for Reproductive Medicine is accepting applications for its 2015 Research Grants, an annual program designed to facilitate the research endeavors of new investigators; provide bridge funds for projects that are of benefit to other members of the society; and foster the development of innovative research.
ASRM research grants of up to $50,000 will be awarded for project expenses, technical assistance, patient expenses, research supplies, and durable laboratory equipment. Innovative projects or projects that have previously been funded by other sources and are in need of bridge funding are appropriate. Proposals from junior faculty, particularly those in their first three years of faculty appointment, will receive priority.
To be eligible, applicants must have earned an M.D. and/or Ph.D. and/or D.O. and/or D.V.M. degree or their equivalents; be an independent investigator who has completed his/her training and has a full-time faculty/research staff appointment as of July 1, 2015; and have been an active or associate member of ASRM since at least July 1, 2014.
Please visit the ASRM website for complete program guideline, information about previous grant recipients, and application instructions.
AWARDS AND HONOURS:
FoM Internal Deadline: October 29, 2015
The Ho-Am Prize was established in 1990 by Kun-Hee Lee, the Chairman of Samsung, with a vision to create a new corporate culture that continues the noble spirit of public service espoused by the late Chairman Byung-chull Lee, founder of Samsung.
The Prize, named after the late Chairman’s sobriquet, is presented each year to individuals who have contributed to academics, the arts, and social development, or who have furthered the welfare of humanity through distinguished accomplishments in their respective professional fields.
The Prize for Medicine includes the clinical and research areas of medicine, physiology, and pharmacology. The Prize is awarded to people of Korean heritage who have made distinctive contributions to the efforts of humankind to conquer the disease.
Recipients of the Ho-Am Prize are each presented with Diploma, a pure gold medal (187.5g) and a cash prize of KRW 300million (approx. CDN$338,000).
The Dean will review nominations and submit one to the Ho-Am Foundation. Please send the following to Bryan Wong (firstname.lastname@example.org) by October 29th:
- A detailed description of the nominee’s primary achievements in his/her field, including reasons for the nomination
- 1 representative thesis, and 5 related theses.
- CV with bibliography
- Letters of support (optional)
- Note: Nominee must be of Korean ethnic origin. Ho-Am Foundation has determined this in the past by reviewing the CV; if necessary, they will contact nominee directly during the review process
Please visit the Ho-Am Prize website for further details.
FoM Internal Deadline: October 29, 2015
The Drukier Prize in Children’s Health Research will recognize the work of an early career pediatrician, and is intended for someone who holds an MD or MD/PhD degree, has completed clinical training and who has started his/her first faculty position no earlier than July 1, 2005. Nominees should be investigators who through their basic, translational or clinical research have made important contributions towards improving the health and well-being of infants, children and/or adolescents. The winner will receive a $10,000 unrestricted honorarium and will be honored at a reception in New York City.
The Dean will review nominations and submit a maximum of two. Please send the following to Bryan Wong (email@example.com) by October 29th:
- A letter of nomination in MS Word format describing the impact of the nominee’s research on the health of children
- Copies of the five most significant papers published by the nominee with a statement describing the nominee’s contribution to these papers.
- CV with bibliography
Please visit the Weill Cornell Medical College website for further details.
FoM Internal Deadline: October 29, 2015
The Warren Alpert Foundation Prize, in association with Harvard Medical School, recognizes and honors one or more scientists, physicians and researchers whose scientific achievements have led to the prevention, cure or treatment of human diseases or disorders, and/or whose research constitutes a seminal scientific finding that holds great promise of ultimately changing our understanding of or ability to treat disease.
Nominations are accepted from academic institutions, centers of research, government, or other biomedical institutions from around the world. Self-nominations are not accepted. The prize is open to both U.S. and non-U.S. citizens.
The value prize is US$500,000 (to be split equally if more than one recipient is selected), a citation and plaque.
A special scientific symposium in honor of the recipient(s) is held each year on the first Thursday in October at Harvard Medical School.
The Dean will review and submit suitable nominations. As per the Warren Alpert Foundation nomination requirements, please send the following to Bryan Wong (firstname.lastname@example.org) by October 29th:
- Description of the nominee’s research as it relates to the nomination
- An explanation of why this person or group should be nominated over others who have made significant contributions in the same area of research
- CV with bibliography
- Two letters of support
Please visit the Warren Alpert Foundation Prize website for further details.
Date & Time: See below
Location: See below
The Michael Smith Foundation for Health Research (MSFHR) will be providing information sessions on the recently-announced MSFHR 2016 Scholar competition (LOI deadline: Nov. 6, 2015; Full Application deadline: Dec. 15, 2015). The session will be available at the following sites and dates:
- Providence Health Care (St. Paul’s Hospital)
When: Tuesday, October 20; 10 a.m. to 12 p.m.
Where: Gourlay Conference Room, 1st Floor – Burrard Building, St. Paul’s Hospital (1081 Burrard Street, Vancouver)
Contact: Shemim Manji, Centre for Heart & Lung Innovation (email@example.com or 604-806-9033)
- University of Victoria
When: Wednesday, October 21; 10 a.m. to 12 p.m.
Where: Administrative Services Building – Boardroom 220 (3800 Finnerty Road, Victoria)
Contact: Nicole Kitson, Senior Grants Officer (firstname.lastname@example.org or 250-853-3103)
- University of British Columbia (Point Grey Campus)
When: Friday, October 23; 2 p.m. to 4 p.m.
Where: Room B151, School of Population & Public Health (2206 East Mall, Vancouver)
Contact: Christy McTait, Health Grant Development Officer (email@example.com or 604-827-5615)
- University of British Columbia (Okanagan Campus)
When: Wednesday, October 28, 10 a.m. to 12 p.m.
Where: Fipke Building – Room 250, UBC Okanagan Campus (3247 University Way, Kelowna)
Contact: Kristen Korberg, Associate Director (firstname.lastname@example.org or 250-807-8832)
- Vancouver Coastal Health Research Institute (Vancouver General Hospital)
When: Thursday, October 29; 10 a.m. to 12 p.m.
Where: Diamond Health Care Centre – Room 9299 (2775 Laurel Street, Vancouver)
Contact: Kerri Abramson, Manager, Research Education & Internal Awards (email@example.com or 604-875-4111)
Each session will be led by MSFHR’s Research Programs Team and will consist of a 30-minute PowerPoint presentation with an overview of the changes in guidelines and eligibility criteria followed by an open Q&A session. The session is intended for researchers and health professionals who are seeking to launch an independent research career in biomedical, clinical, health services, population health research fields, as well as research administrators and grant facilitators.
Date & Time: October 23, 2015; 9-10am
Location: Room B151, SPPH Building, 2206 East Mall, Vancouver
This presentation explores the intersection of healthcare and public health and its implications for bioethics thinking and practice. Using examples of ‘wicked problems’ emerging at this intersection — such as Ebola, drug supply shortages, complex chronic disease, and ‘big data’ – Dr. Gibson argues that the traditional paradigms of healthcare ethics (with its focus on individuals) and public health ethics (with its focus on populations) are ill-suited by themselves to tackle these complex issues and that a new integrative bioethics is needed.
Dr. Jennifer Gibson is Sun Life Financial Chair in Bioethics and Director of the University of Toronto Joint Centre for Bioethics (JCB), Associate Professor in the Institute of Health Policy, Management & Evaluation (IHPME), and Director of the World Health Organization (WHO) Collaborating Centre for Bioethics at the University of Toronto. Jennifer has a PhD in Philosophy (bioethics and political theory). Her research focuses on ethical governance and performance of health organizations and systems. Jennifer has served on government and public sector policy advisory committees concerning public health emergencies, critical care triage, drug funding and supply, and organ transplantation. She chaired the Ebola Bioethics Table of the Ontario Ministry of Health and Long Term Care and was a member of the WHO Ethics Working Group on Ebola. Currently, she co-chairs the Governance Sub-Group of the WHO Ethics and Public Health Surveillance Guidelines Working Group. In addition to her research and service activity, she supervises graduate students in the Collaborative Program in Bioethics and teaches resource allocation ethics in the MHSc program in Bioethics.
Date & Time: October 23, 2015; 12:15 – 1:30pm
Location: Room 1891 Jim Pattison Pavilion South Paetzold Theatre, Vancouver General Hospital
This is a reminder for this Month’s Professional Advancement Learning Series (PALS): “Making Things Better: using LEAN methodology for continuous improvement” by Dr. Tyler Smith and Jackie O’Connell.
After attending this session, you will learn:
- The VGH Lab vision
- The history of Lean
- The fundamental principles of Lean
- Lean tools commonly used in the workplace
Lunch: 12:15pm – 12:30pm
Lecture: 12:30pm – 1:30pm
*Video conferencing available at UBC LSC1312, SPH 4/5 and BCCH CSB V2-222
* Audio Bridge: ID 30229 (1-877-792-2768)
* Lunch will be served 15 minutes prior to the session free of charge.
Please note, this is a mandatory course for all Pathology PGY2-5 residents. If you cannot attend, please notify our office in writing.
Faculty, Graduate Students and others are also welcome to attend.
Note for Radiology and ID managers: please feel free to forward this invite to your residents.
Notes about credit evaluation: for Faculty, Graduate Students, Fellows and others, Credit Evaluation Form isattached for your use. You can submit to firstname.lastname@example.org after the event for credit purpose or providing feedback. All the evaluations will be provided to the presenter(s) anonymously.
For more information on past events, please visit UBC Pathology PALS Website.
Date: November 21, 2015
Location: St. Paul’s Hospital, Vancouver BC
Target audience: Emergency Physicians, Family Physicians, Residents & Students
Accreditation: Up to 6.5 Mainpro M1/MOC Section 1 Credits
A new, one day course designed for Emergency Physicians to review and improve skills and use of equipment in managing emergent ophthalmic cases. Lots of time to practice with models and equipment!